Comparison of GATA3, GCDFP15, Mammaglobin and SOX10 Immunocytochemistry in Aspirates of Metastatic Breast Cancer

被引:3
作者
Li, Joshua J. X. [1 ]
Ng, Joanna K. M. [1 ]
Lee, Conrad H. C. [1 ]
Tang, Cheuk-Yin [1 ]
Tsang, Julia Y. S. [1 ]
Tse, Gary M. [1 ]
机构
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, Hong Kong 999077, Peoples R China
来源
JOURNAL OF MOLECULAR PATHOLOGY | 2022年 / 3卷 / 04期
关键词
aspiration cytology; breast cancer; GATA3; GCDFP15; mammaglobin; SOX10; immunocytochemistry; ESTROGEN; RECEPTOR;
D O I
10.3390/jmp3040019
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Introduction: Metastatic cancers are frequently detected on fine-needle aspiration (FNA) cytology, and confirmation of metastatic breast cancer often requires immunocytochemistry. Tissue provisioning for FNA specimens is important. In this study, GATA3, gross cystic disease fluid protein-15 (GCDFP15), mammaglobin (MMG), and SOX10 were performed on cell block preparations from aspirates of histologically confirmed metastatic breast cancers. The diagnostic performance of single markers and combinations of these markers were investigated with the aim to construct a tissue-efficient immunopanel. Methodology: Aspirates of metastatic breast cancer with corresponding histology and biomarker (estrogen receptor (ER), progesterone receptor (PR), HER2 and ki67) profile were retrieved. ER, GATA3, GCDFP15, MMG and SOX10 immunostains were performed on cell block sections and their expressions were assessed and compared. Results: Immunostaining was performed on a total of 115 aspirates. GATA3 showed the highest expression, followed by MMG, GCDFP15 and SOX10. Twenty-three, five and five cases expressed GATA3, MMG and SOX10 only. The five cases expressing SOX10 only were ER negative, and SOX10 expression was negatively associated with ER (p = 0.001), MMG (p = 0.001), GCDFP15 (p = 0.010) and GATA3 (p = 0.002), whereas GATA3 expression showed positive correlation with ER positivity (p < 0.001). MMG and GCDFP15 showed association with high Ki67 (p < 0.05), and no correlations were found with HER2 expression. Conclusion: In this cohort, GATA3 was the most sensitive single marker. The addition of MMG and SOX10 increases the sensitivity for detection of ER positive and ER negative breast cancers, respectively. These findings support the use of a combination of GATA3/MMG/SOX10 for confirmation of metastatic breast cancer.
引用
收藏
页码:219 / 227
页数:9
相关论文
共 18 条
  • [1] Estrogen and Progesterone Receptor Testing in Breast Cancer American Society of Clinical Oncology/College of American Pathologists Guideline Update
    Allison, Kimberly H.
    Hammond, M. Elizabeth H.
    Dowsett, Mitchell
    McKernin, Shannon E.
    Carey, Lisa A.
    Fitzgibbons, Patrick L.
    Hayes, Daniel F.
    Lakhani, Sunil R.
    Chavez-MacGregor, Mariana
    Perlmutter, Jane
    Perou, Charles M.
    Regan, Meredith M.
    Rimm, David L.
    Symmans, W. Fraser
    Torlakovic, Emina E.
    Varella, Leticia
    Viale, Giuseppe
    Weisberg, Tracey F.
    McShane, Lisa M.
    Wolff, Antonio C.
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2020, 144 (05) : 545 - 563
  • [2] Combined SOX10 GATA3 is most sensitive in detecting primary and metastatic breast cancers: a comparative study of breast markers in multiple tumors
    Aphivatanasiri, Chaiwat
    Li, Joshua
    Chan, Ronald
    Jamidi, Shirley K.
    Tsang, Julia Y.
    Poon, Ivan K.
    Shao, Yan
    Tong, Joanna
    To, Ka-Fai
    Chan, Siu-Ki
    Tam, Fiona
    Cheung, Sai-Yin
    Shea, Ka-Ho
    Tse, Gary M.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2020, 184 (01) : 11 - 21
  • [3] Complications after fine-needle aspiration cytology: a retrospective study of 7449 consecutive thyroid nodules
    Cappelli, C.
    Pirola, I.
    Agosti, B.
    Tironi, A.
    Gandossi, E.
    Incardona, P.
    Marini, F.
    Guerini, A.
    Castellano, M.
    [J]. BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2017, 55 (03) : 266 - 269
  • [4] The role of cytokeratin 7/20 coordination revisited-Machine learning identifies improved interpretative algorithms for cell block immunohistochemistry in aspirates of metastatic carcinoma
    Chan, Ronald Cheong Kin
    Lee, Angus Lang Sun
    To, Curtis Chun Kit
    Cheung, Tommy Lok Him
    Ho, Ching Ting
    Choi, Joseph Sen Hei
    Li, Joshua Jing Xi
    [J]. CANCER CYTOPATHOLOGY, 2022, 130 (06) : 455 - 468
  • [5] Sry-related high-mobility-group/HMG box 10 (SOX10) as a sensitive marker for triple-negative breast cancer
    Jamidi, Shirley K.
    Hu, Jintao
    Aphivatanasiri, Chaiwat
    Tsang, Julia Y.
    Poon, Ivan K.
    Li, Joshua J.
    Chan, Siu-Ki
    Cheung, Sai-Yin
    Tse, Gary M.
    [J]. HISTOPATHOLOGY, 2020, 77 (06) : 936 - 948
  • [6] Jhala Darshana, 2011, Patholog Res Int, V2011, P281930, DOI 10.4061/2011/281930
  • [7] Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy
    Kuukasjarvi, T
    Kononen, J
    Helin, H
    Holli, K
    Isola, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (09) : 2584 - 2589
  • [8] Marker assessments in ER-positive breast cancers: old markers, new applications?
    Li, Joshua J. X.
    Tse, Gary M.
    [J]. HISTOPATHOLOGY, 2023, 82 (02) : 218 - 231
  • [9] Cervical lymph node metastases from remote primary tumor sites
    Lopez, Fernando
    Rodrigo, Juan P.
    Silver, Carl E.
    Haigentz, Missak, Jr.
    Bishop, Justin A.
    Strojan, Primoz
    Hartl, Dana M.
    Bradley, Patrick J.
    Mendenhall, William M.
    Suarez, Carlos
    Takes, Robert P.
    Hamoir, Marc
    Robbins, K. Thomas
    Shaha, Ashok R.
    Werner, Jochen A.
    Rinaldo, Alessandra
    Ferlito, Alfio
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 : E2374 - E2385
  • [10] GATA-3 is superior to GCDFP-15 and mammaglobin to identify primary and metastatic breast cancer
    Ni, Yun-Bi
    Tsang, Julia Y. S.
    Shao, Mu-Min
    Chan, Siu-Ki
    Cheung, Sai-Yin
    Tong, Joanna
    To, Ka-Fai
    Tse, Gary M.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2018, 169 (01) : 25 - 32